ASH Joined Sign-on Letter to FDA on LDT Proposed Rule
Citations
American Society of Hematology. (2023).
ASH Joined Sign-on Letter to FDA on LDT Proposed Rule.
Retrieved from https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-joined-sign-on-letter-to-fda-on-ldt-proposed-rule.
American Society of Hematology.
"ASH Joined Sign-on Letter to FDA on LDT Proposed Rule." Hematology.org.
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-joined-sign-on-letter-to-fda-on-ldt-proposed-rule
(label-accessed February 12, 2025).
"American Society of Hematology."
ASH Joined Sign-on Letter to FDA on LDT Proposed Rule, 12 Feb. 2025 ,
https://www.hematology.org/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-joined-sign-on-letter-to-fda-on-ldt-proposed-rule.